The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Travel stocks soar as encouraging vaccine study lifts Europe

Wed, 15th Jul 2020 09:41

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Euro zone blue-chips hit highest since March 5

* Italy's Atlantia soars as end of concession dispute nears

* Sweden's SEB slips as loan loss provision surges

* All eyes on ECB meeting, EU summit later this week
(Updates to market close)

By Sruthi Shankar

July 15 (Reuters) - European stocks closed at over a
five-week high on Wednesday, with travel stocks surfing a wave
of optimism following reports of progress in developing a
COVID-19 vaccine.

Hard-hit airline stocks like British Airways-owner IAG
, Ryanair and Lufthansa rose between
9.7% and 10.7%, while cruise operator Carnival Plc
jumped 11.4%.

The travel & leisure index surged 6.1% to lead
sectoral gains, but still remains the worst performer in Europe
this year with a 33% plunge as the coronavirus pandemic brought
global travel to a halt.

The pan-European STOXX 600 rose 1.8%, closing just
short of levels last seen in early March, while euro zone
blue-chips jumped 1.7% to hit their highest level
since March 5.

Investors were encouraged by an early-stage study on U.S.
biotech firm Moderna Inc's experimental vaccine for
COVID-19 that provoked immune responses.

Meanwhile, AstraZeneca jumped 5.2% after a report
said positive news on the University of Oxford's potential
COVID-19 vaccine that has been licensed to the drugmaker could
be announced as soon as Thursday.

"Our central scenario is that a vaccine would be broadly
available from the second quarter of next year, or the fourth
quarter of this year in our upside scenario," Mark Haefele,
chief investment officer of UBS Global Wealth Management, told
clients.

"Various potential treatment options are also in the
pipeline, raising hopes that societies can cope with the
pandemic without full shutdowns."

Expectations were also high among investors heading into an
EU summit later this week that leaders will agree on a recovery
fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank concludes its policy meeting on
Thursday although no major announcements are expected.

Among individual movers, Swedish telecom operator Tele2 AB
gained 2.9% as it reaffirmed its 2020 earnings
outlook and plans for an extra shareholder payout.

The world's largest fish farmer Mowi ASA jumped
6.8% as harvest volumes beat its own forecast. Shares in peer
Salmar rose 2.2%.

The top gainer on the STOXX 600 was Atlantia SpA,
which shot up 26.7% after the Italian infrastructure group and
its unit Autostrade made the government new offers to settle
their long-running dispute.

Semiconductor equipment maker ASML Holding NV
declined 3.7% as it reported quarterly profit below estimates,
but forecast overall growth for 2020.

Swedish bank SEB AB fell 1.6% after reporting a
smaller-than-expected fall in net quarterly profit, but credit
loss provisions surged. Handelsbanken AB also dropped
2.6%.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Catherine Evans)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.